NV-RIMINI-STREET
3.6.2019 15:02:06 CEST | Business Wire | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Grupo Ferroeste, Brazil’s leading manufacturer of steel, fuel and energy, switched to Rimini Street support and is estimating a R$2 million of savings in total support costs through 2025. Grupo Ferroeste moved to Rimini Street support for its SAP ECC 6.0 system in 2018. By switching to Rimini Street, the company realized savings of 50 percent in its annual maintenance fees and now receives a premium-level, ultra-responsive support for its current, robust SAP system for a minimum of 15 years from the time it transitioned to Rimini Street. In addition, Grupo Ferroeste has been liberated from the vendor’s dictated roadmap of continuous upgrades and updates, and is able to move forward with their own business-driven IT roadmap. As part of their roadmap and by leveraging their substantial maintenance savings, the company has restructured its technology department and has planned for several cloud and digital transformation initiatives.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190603005041/en/
Improved Support Model Optimizes Efficiency
Grupo Ferroeste was created in the state of Minas Gerais 40 years ago and includes companies such as AVB , CBF Indústria and CVB . The company operates mills in the steel, fuel and energy segments, producing steel, pig iron, alcohol, air gases and cement in a 24x7 model and cannot afford to be impacted by IT issues. Reducing costs, increasing productivity and innovating for continued growth are essential pillars in Grupo Ferroeste’s business strategy. The organization determined it needed a change to fully meet these goals and began a series of initiatives to restructure the IT department and improve internal efficiency.
During this restructure, Grupo Ferroeste realized their enterprise software vendor maintenance fees were extremely high – about 22% of the total cost of their license agreements. Furthermore, the service from the vendor seemed very slow – the vendor would take days or sometimes weeks to respond to issues raised – and the company was in need of an agile and efficient partner to support its ERP system. After reviewing third-party support providers, Grupo Ferroeste was able to show their board the financial impact and strategic capabilities of working with Rimini Street. Additionally, the organization spoke with several Rimini Street clients in Brazil about the benefits of switching from SAP to Rimini Street for ERP support, and how the move would accelerate Grupo Ferroeste’s business-driven IT roadmap versus the company being locked into a vendor-dictated plan. Now, with this improved support model, Grupo Ferroeste can better focus its resources and direct its investments toward strategic initiatives and business transformation.
“We needed efficient support as well as a strategic partner to help accelerate our digital transformation journey, and I was seeing a market trend of switching to third-party support to alleviate the disadvantages of vendor control and wanted to take advantage of this opportunity,” said Enéas de Alcântara Silva, IT manager at Grupo Ferroeste. “The slow response from the vendor was causing too many delays internally, but now we have ultra-responsive support from Rimini Street, and have experienced response times in as little as 1 minute regardless of the type of problem, which has been a nice surprise. Everything is done directly with a dedicated, experienced technical specialist, which is a great differentiator in customer care. If an organization is looking to move away from vendor maintenance support, I would highly recommend considering Rimini Street.”
As with all Rimini Street clients, Grupo Ferroeste was assigned a senior level Rimini Street Primary Support Engineer (PSE) – each Rimini Street PSE has an average of 15 years’ experience. Grupo Ferroeste also receives Rimini Street’s industry-leading service level agreement (SLA) guaranteeing access to a team of local engineers 24/7/365 to address any support issues, and a 15-minute response time for Priority 1 critical cases.
Reducing Spend with Added Services
In addition to a vastly improved support model and the ability to optimize IT resources and leverage significant savings, another benefit of moving to Rimini Street is the Company’s support for Brazil tax, legal and regulatory updates. These complex updates are provided through Rimini Street’s innovative combination of patent-pending tax, legal and regulatory technology, a proven methodology, and ISO 9001-certified development processes to ensure clients receive accurate, high-quality deliverables.
“If we had continued with SAP support, we would have to pay additional consulting costs to adjust to the new tax, legal and regulatory obligations at the time, such as REINF and Nota Fiscal Eletrônica 4.0, the Electronic Invoice,” continued Enéas de Alcântara Silva. “And now, with Rimini Street, these fiscal projects are developed within the support contract itself, with no additional cost.”
“Grupo Ferroeste has been able to experience Rimini Street’s premium level support, which was vastly different from what they had experienced with the original software vendor, and were also able to free up ample savings to put towards digital transformation,” said Edenize Maron , general manager, Latin America. “As with so many of Rimini Street’s clients, Grupo Ferroeste was able to unshackle themselves from vendor lock-in and put into motion their business-driven roadmap, while at the same time increasing their productivity internally.”
About Rimini Street, Inc.
Rimini Street, Inc. (Nasdaq: RMNI) is a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner. The Company has redefined enterprise software support services since 2005 with an innovative, award-winning program that enables licensees of IBM, Microsoft, Oracle, Salesforce, SAP and other enterprise software vendors to save up to 90 percent on total maintenance costs. Clients can remain on their current software release without any required upgrades for a minimum of 15 years. Over 1,850 global Fortune 500, midmarket, public sector and other organizations from a broad range of industries currently rely on Rimini Street as their trusted, third-party support provider. To learn more, please visit https://www.riministreet.com follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn . (C-RMNI)
Forward-Looking Statements
Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may,” “should,” “would,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “seem,” “seek,” “continue,” “future,” “will,” “expect,” “outlook” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, changes in the business environment in which Rimini Street operates, including inflation and interest rates, and general financial, economic, regulatory and political conditions affecting the industry in which Rimini Street operates; adverse developments in pending litigation or in the government inquiry or any new litigation; the final amount and timing of any refunds from Oracle related to our litigation; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth initiatives; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the terms and impact of our outstanding 13.00% Series A Preferred Stock; changes in taxes, laws and regulations; competitive product and pricing activity; difficulties of managing growth profitably; the success of our recently introduced products and services, including Rimini Street Mobility, Rimini Street Analytics, Rimini Street Advanced Database Security, and services for Salesforce Sales Cloud and Service Cloud products, in addition to products and services we expect to introduce in the near future; the loss of one or more members of Rimini Street’s management team; uncertainty as to the long-term value of Rimini Street’s equity securities; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on May 9, 2019, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.
© 2019 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190603005041/en/
Contact:
Michelle McGlocklin Rimini Street, Inc. +1 925 523-8414 mmcglocklin@riministreet.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
